A review of lung cancer in the atomic bomb survivors — Treated cases at Nagasaki Atomic Bomb Hospital from 1983–1990 (Englisch)
Nationallizenz
Susumu NAKAO M.D, Naoki FUJISE M.D., Hironobu TOCHIKA M.D., Toshiyo ISHII M.D., Kazuyuki EIDA M.D., ∗Naomi ITO M.D., ∗∗Osamu TAKAHARA M.D. Department of Surgery, ∗Department of Internal medicine, ∗∗Department of Pathology, Japanese Red Cross, Nagasaki Atomic Bomb Hosp.
In:
Lung Cancer
;
7
;
3
;
1991
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:A review of lung cancer in the atomic bomb survivors — Treated cases at Nagasaki Atomic Bomb Hospital from 1983–1990
-
Untertitel:Susumu NAKAO M.D, Naoki FUJISE M.D., Hironobu TOCHIKA M.D., Toshiyo ISHII M.D., Kazuyuki EIDA M.D., ∗Naomi ITO M.D., ∗∗Osamu TAKAHARA M.D. Department of Surgery, ∗Department of Internal medicine, ∗∗Department of Pathology, Japanese Red Cross, Nagasaki Atomic Bomb Hosp.
-
Erschienen in:Lung Cancer ; 7 ; 3
-
Verlag:
-
Erscheinungsdatum:01.01.1991
-
Format / Umfang:1 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Dose response relationships for asbestos and lung cancer| 1991
- 1
-
IntroductionVan Houtte, P. et al. | 1991
- 1
-
Relationship between smoking and lung cancer cell typeDu, Y.X. / Cha, Q. / Chen, Y.Z. et al. | 1991
- 2
-
A comparative study of lung cancer in black and white patientsSmith, C / Feldman, C / Zwi, S / Kallenbach, JM et al. | 1991
- 2
-
Analysis of the relationship between lung cancer cell type and some associated factorsLei, Y.X. / Du, Y.X. / Chen, Y.Z. et al. | 1991
- 2
-
Atmospheric pollution and human lung cancerDu, Y.X. / Feng, J.W. / Chen, Y.Z. / Wu, J.M. et al. | 1991
- 2
-
Lung cancer cases analysis in the annual of pathological autopsy cases in Japan (1958–1989)| 1991
- 3
-
Lung cancer at a young age in New Zealand| 1991
- 3
-
Prognostic factors in non-small cell lung cancer: a consensus reportFeld, Ronald / Arriagada, Rodrigo / Ball, David L. / Mattson, Karin / S∅rensen, Jens Benn et al. | 1991
- 3
-
Five year results of new lung cancer screening programme using mass miniature radiograph| 1991
- 3
-
A review of lung cancer in the atomic bomb survivors — Treated cases at Nagasaki Atomic Bomb Hospital from 1983–1990| 1991
- 3
-
The risk factors for lung cancer in womenXu-Dong, Dai / Xi-Wen, Son / Su-Fen, Yu et al. | 1991
- 4
-
Carcinogenesis studies of the extract of Aspergillus versicolor culture on the human fetal lung tissue in vitro| 1991
- 4
-
Histological sub-type of lung cancer is subject to age and sex specific differences| 1991
- 4
-
Mycotoxins and Lung Cancer| 1991
- 4
-
Incidence of lung cancer (LC) in middle-aged Japanese company employees| 1991
- 5
-
Risk and type of lung cancer and mesothelioma in patients with pleural plaquesMD,FCCP Hillerdal, Gunnar et al. | 1991
- 5
-
Lung cancer among married couplesMäkipaja, K et al. | 1991
- 5
-
The lung cancer registration project in Flanders (Belgium): An interim analysis of the first 1000 casesVan Meerbeeck, J. / Weyler, J. / Uydebrouck, M. / Deneffe, G. / Joos, G. / Van de Maele, B. / Van den Eeckhout, A. et al. | 1991
- 5
-
Lung cancer in New South WalesMcCredie, Margaret / Coates, Marylon / Taylor, Richard et al. | 1991
- 6
-
The problem of the future. The discrepancy between numbers of new cancers totally, lung cancer especially and the society as a whole in year 2010| 1991
- 6
-
The occupational distribution of mortality of lung cancer in Shijiazhuang| 1991
- 6
-
A case-control study on risk factors of lung cancer in no-smoking woman in rural area, China| 1991
- 6
-
Predictive value of current cigarette smoking, pack years and tar exposure in the estimation of lung cancer riskVirtamo, J / Taylor, PR / Huttunen, JK / Edwards, BK / Järvinen, P / Haapakoski, J / Hartman, A / Haukka, J / Heinonen, OP / Albanes, D et al. | 1991
- 7
-
Lung Cancer in young patientsOrphanidou, D. / Veslemes, M. / Tsintiris, K. / Vamvouni, C. / Vasalos, P. / Manias, A. / Chatzinicolaou, V. / Damianaki, A. / Rapakoulias, P. / Jordanoglou, J. et al. | 1991
- 7
-
Bronchogenic carcinoma in the elderly veteransChin, HW / Ampil, F / Anderson, WM / Barker, R et al. | 1991
- 7
-
Pretreatment minimal staging for non-small cell lung cancers: a consensus reportGoldstraw, P. / Bureau, G. / Cullen, M. / Dabouis, G. / Deneffe, G. / Drings, P. / Harper, P. / Lacquet, L. / Latto, G. / Pastorino, U. et al. | 1991
- 8
-
Asbestos program in FinlandMD,FCCP Huuskonen, Matti S. et al. | 1991
- 8
-
Antismoking programme addressed to women| 1991
- 9
-
Antismoking programme addressed to military personnel| 1991
- 9
-
Antismoking programme in the school| 1991
- 9
-
Abstract part I the European action against tobaccoTubiana, Maurice et al. | 1991
- 9
-
Yearly courses for teachers| 1991
- 10
-
Abstract part II the European action against tobaccoTubiana, Maurice et al. | 1991
- 10
-
Abstract part III the European action against tobaccoTubiana, Maurice et al. | 1991
- 10
-
Detecting lung cancer in a large cohort| 1991
- 10
-
Evaluation of smoking habit among young population for targeting anti-smoking campaign| 1991
- 11
-
Characteristics of lung cancer and indoor air pollution in Xuan Wei, China| 1991
- 11
-
ATBC lung cancer prevention study| 1991
- 11
-
Postoperative adjuvant treatments for non-small cell lung cancers: a consensus reportHolmes, E.C. / Bleehen, N.M. / Le Chevalier, T. / Ettinger, D. / Jett, J.R. / Johnson, D. / Komaki, R. / Saijo, N. / Sause, W. / Trovo, M. et al. | 1991
- 11
-
The process and impact of a hospital becoming smoke-freeMcCall, CB / Carr, DT / Eriksen, MP et al. | 1991
- 11
-
A randomized chemoprevention trial in stage I lung cancer with high-dose retinol palmitatePastorino, U. / Infante, M. / Maioli, M / Chiesa, G. / Clerici, M. / Soresi, E. / Valente, M. / Belloni, PA / Ravasi, G. et al. | 1991
- 12
-
Differential expression of cell adhesion molecules on lung cancer cell lines| 1991
- 12
-
A study of IL-2 activity changes of lung cancer patientsXing, ZL / Wang, YZ et al. | 1991
- 13
-
The cultivation of human embryo broncho-epithelia cell (HEBE) treated with carcinogens and sex hormonesDu, Y.X. / Gao, H.G. / Jin, B. / Zhan, D.J. et al. | 1991
- 13
-
Serum levels of ferritin in patients with lung cancer (LC)Ferrigno, D. / FCCP Buccheri, GF. et al. | 1991
- 13
-
Chemosensitivity of transplantable non-small cell bronchial rat tumours growing subcutaneously or in the lung| 1991
- 13
-
Metabolism of benzo(a)pyrene by human fetal lung microsomeJin, B. / Chen, J.K. / Yi, F. / Du, Y.X. et al. | 1991
- 14
-
Chemiluminescence responses of alveolar macrophages obtained from each lung in patients with lung cancerHosker, HSR / Page, RL / Muers, MF et al. | 1991
- 14
-
Characterization of the L-MYC promoter: Promoter activity and DNA: Protein binding sites| 1991
- 14
-
Autocrine motility factor-like substance (AMF) in human lung cancer cell lines| 1991
- 14
-
A new monoclonal antibody against a marker for squamous cell differentiation in human lung cancervan Duijnhoven, Hans L.P. / Schalkwijk, Joost / Kranenborg, Marion H.G.C. / Sc. Wagenaar, Sjoend / Springall, David R. / Polak, Julia M. / Wim, J.M.van de Ven et al. | 1991
- 15
-
Induction therapy for NSCLC: a consensus reportKlastersky, Jean / Burkes, Ronald / Choi, Noah / Dombernowsky, Per / Darwish, Samir / Ginsberg, Robert J. / Gregor, Anna / Ihde, Daniel C. / Kocha, Walter / MacBeth, Fergus et al. | 1991
- 15
-
Blood neutrophil and monocyte function following chemotherapy in patients with small cell lung cancerHosker, HSR / Scott, Y / Kesteven, P / Corris, PA et al. | 1991
- 15
-
A new differentiation marker for small-cell lung cancer (SCLC) cell lines: a compound with γ-enolase antigen but without enzym activitySplinter, T.A.W. / Verkoelen, C. / Vlastuln, M. / v.d. Gaast, A. et al. | 1991
- 15
-
An immunohistochemical study of cellular proliferation markers in CDDP resistant and sensitive tumors in non-small cell lung cancer| 1991
- 15
-
Small cell lung cancer (SCLC) antigens are expressed differently on human continuous cultured cell lines representing SCLC “classic,” “variant,” and carcinoid phenotypesKoros, A.M.C. / Atchison, R.W. / Mitchell, D.L. et al. | 1991
- 16
-
Induction of lymphokine-activated killer(LAK) activity and its regulation by blood monocytes in patients with lung cancer| 1991
- 16
-
New serum cancer-associated protein as a reliable tumor marker of lung cancer| 1991
- 16
-
Study on biological characteristics of human lung adenocarcinoma cells with different metastatic phynotypes| 1991
- 16
-
An orthotopic model system for human lung cancer| 1991
- 17
-
Inhibition of human lung cancer metastasis using antiplatelet drug and sialidase| 1991
- 17
-
Metastatic potential of human lung adenocarcinoma correlate with plasminogen activator production, not correlate with platelet aggregating potential and cell attachment activityAdachi, Toshiyuki / Inufusa, Haruhiko / Mori, Nobuhira / Hara, Satoshi / Tanaka, Nobuya / Nakamura, Masato / Yasutomi, Masayuki et al. | 1991
- 17
-
Synergistic effects of chemotherapy and anti-epidermal growth factor receptor (EGFr) monoclonal antibodies (MAb)| 1991
- 17
-
Genetic changes in pre-invasive lesions of the respiratory tract| 1991
- 18
-
Lung tumour cell proliferation may be driven by multiple bombesin-related peptides| 1991
- 18
-
Expression of multiple binding protein genes by human lung tumour cell lines| 1991
- 18
-
Establishment of doxorubicin-resistant human small-cell lung cancer cell line(SBC-3/DXR) and effect of new synthetic anthracyline analogs and antifolates| 1991
- 18
-
Effects of unilateral lung collapse on development of lung tumor in miceKawamura, Ken / Katayama, Hiroo / Takemoto, Kazuo / Matsumoto, Kunihiko et al. | 1991
- 19
-
Study of cell kenetics in human lung cancer and “so called” precancerous conditions in the lung and bronchiMorohoshi, T. / Shimizu, A. / Kameda, Y. / Ishibashi, M. / Nakayama, H. / Matsumoto, A. et al. | 1991
- 19
-
CDDP-resistant (SBC-3/CDDP) and VP16-resistant (SBC-3/VP16) small cell lung cancer(SCLC) cells show a unique collateral sensitivity in culture| 1991
- 19
-
Drug-resistant small cell lung cancer (SCLC) cells are more sensitive to lonidamine (LND), a new cytotoxic agent, than the parent cells| 1991
- 19
-
Quality control in NSCLC treatment: a consensus reportRoemans, P. / Emami, B. / Cox, J. / Pacagnella, A. / Holsti, L. / Monteau, M. / Helle, P. / Comis, R. / Schaake, C. et al. | 1991
- 19
-
Expression of tenascin in human primary lung cancers| 1991
- 20
-
In vitro induction of HLA-DR antigen expression in human lung cancer cells| 1991
- 20
-
Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radioresistance in cis-diamminedichloroplatinum (II) resistant lung cancer cell line| 1991
- 20
-
Basic fetoprotein (BFP) in primary lung cancerFujita, Yukihisa / Goto, Takechika / Fujii, Tsuneo / Hiramori, Norihiro / Kida, Takao / Arimoto, Taichiro / Nakagaki, Yoshinobu / Sakai, Mayuka / Iwasaki, Yoshinobu / Nishiyama, Katsuhiko et al. | 1991
- 20
-
Inhibitory effects of β-carotene on proliferation in vitro and metastasis in vivo of lung cancer cellsLai, BT / Wang, H / Liu, GZ / Jiao, FH / Yan, H et al. | 1991
- 21
-
Pretreatment minimal stagingGoldstraw, Peter et al. | 1991
- 21
-
Competent and priming activities affecting GRP and IGF-I in proliferation of small cell lung cancer cell lines| 1991
- 21
-
Frequency of point mutational activation of the K oncogene in non-small cell lung cancer in Hong Kong| 1991
- 21
-
Sensitivity to etoposide (VP16) and expression of DNA-topoisomerase II (TII) in small cell lung cancer cell lines| 1991
- 21
-
Specific cytolytic T cell clones for an autologous small cell lung cancer (SCLC) cell line| 1991
- 22
-
Different energy metabolism in two small cell lung cancer (SCLC) subpopulations examined by 31P-magnetic resonance spectroscopy (MRS) and biochemical analysis in vivo and in vitro| 1991
- 22
-
Nuclear A-type lamins are differentially expressed in lung cancer subtypes| 1991
- 22
-
Sensitivity to adriamycin of two sets of small cell lung cancer (SCLC) cell lines from individual patients| 1991
- 22
-
Selective reactivity of CIBr monoclonal antibodies (MAb) with lung carcinoma cells| 1991
- 23
-
Expression of adhesion molecules of the cadherin family and of NCAM in small cell lung cancer cell lines and xenografts| 1991
- 23
-
Growth kinetics of small cell lung cancer (SCLC) xenografts grown in nude miceSpang-Thomsen, Mogens / Rygaard, Kåre et al. | 1991
- 23
-
“Tumor pairs” established from the same patient as a model for investigation of drug resistance in human small cell lung cancer| 1991
- 23
-
Differential radiosensitivity of small cell lung cancer (SCLC) cell lines determined by two complementary in vitro assays| 1991
- 24
-
Susceptibility of a human small cell lung cancer (SCLC) cell line to autologous peripheral lymphocytes and induction of tumor-specific killer cells| 1991
- 24
-
Expression of myc family onco-proteins in small cell lung cancer cell lines and xenograftsRygaard, Kåre / Spang-Thomsen, Mogens et al. | 1991
- 24
-
Refractory small cell lung cancer (SCLC) and myc family oncogenes| 1991
- 24
-
Receptors for transforming growth factor β and epidermal growth factor in small cell lung cancer cell lines| 1991
- 25
-
Nuclear DNA content analysis using bronchoscopic brushing specimens of non-small cell lung carcinoma| 1991
- 25
-
Examination of oncogene mRNA in primary lung adenocarcinoma by in situ hybridizationKawamata, Osamu / Inoue, Fumiyuki / Kamikawa, Yasuaki / Funaki, Naoto / Moriki, Yasuyuki / Muramatsu, Tomoyoshi / Hayashi, Doufu / Okabayashi, Takahiro / Horimi, Tadashi / Orita, Kunzo et al. | 1991
- 25
-
Characterization of ectopic production of atrial natriuretic factor (ANF) in a small cell lung cancer cell line and tumor| 1991
- 25
-
Fluorescence properties of lung cancer cell and normal lung cells using LASER and hematoporphyrin derivative| 1991
- 26
-
Expression of the multidrug resistence related mdr-1 gene in human lung and untreated lung cancer| 1991
- 26
-
Effect of topoisomerase II levels on comparative chemosensitivity of lung cancer cell lines| 1991
- 26
-
Gene analysis of pulmonary lymphoproliferative disorders| 1991
- 26
-
Effect of IL-2, IL-6, and IL-8 transfection on the rejection of Lewis lung carcinoma| 1991
- 27
-
Growth inhibition of neuroendocrine lung cancer cell lines via inhibition of peptidyl α-amidation enzyme(s)| 1991
- 27
-
Prognostic factors in patients with non-small cell lung cancer. A critique of the world literatureMaki, E. / Feld, R. et al. | 1991
- 27
-
Production of immunoreactive ProGRP(31-98) in small cell lung carcinomaMiyake, Y. / Nagasaki, K. / Otsubo, K. / Urakami, K. / Saigenji, K. / Yamaguchi, K. et al. | 1991
- 27
-
The expression of growth factors and the corresponding receptors in human non-small cell lung cancer cell lines. Factors of potential importance for auto and paracrine growth regulation| 1991
- 27
-
In vitro and In vivo effects of [D-Arg1,D-Phe5,D-Trp7,9,Leu11] substance P (D-Phe5SP) on the growth of human lung cancer cell lines and xenografts| 1991
- 28
-
Secretary type and intracellular type of thiol protease inhibitors purified from human lung cancer cell lineYoshioka, S. / Kuranishi, F. / Nishiki, M. / Dohi, K. et al. | 1991
- 28
-
Production of tumor necrosis factor alpha (TNF-α) in lung cancer patients| 1991
- 28
-
Screening of point mutations on p53 gene in tissues from primary lung cancer using single-strand conformation polymorphisms analysisMatsuda, Kunihiro / Takahashi, Hideki / Seyama, Kuniaki / Ohwada, Akihiko / Nukiwa, Toshihiro / Kira, Shiro et al. | 1991
- 28
-
Effect of immunomodulator on neutrophils migration to pulmonary alveoli and on alveolar macrophage functions in lung metastasis model| 1991
- 29
-
Anti-proliferative effect of glucocorticoids and anti-glucocorticoids on non-small cell lung cancer in vitroBeattie, C.W. / Bratescu, L. / Thomas, P.A. et al. | 1991
- 29
-
Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer?| 1991
- 29
-
The association between histological type, neuroendocrine differentiation and drug sensitivity of lung cancer cell lines| 1991
- 29
-
Glucocorticoid receptors in squamous lung cancer cell cytosolsThomas, P.A. / Graves, J. / Han, M.C. / Beattie, C.W. et al. | 1991
- 30
-
Nude mice with lacZ transduced human tumor xenografts as an in vivo model for invasion and metastasisSpang-Thomsen, Mogens / Zwiebel, James A. / Rygaard, Jørgen / Brünner, Nils et al. | 1991
- 30
-
Analysis of chromosome abnormalities in pleural effusions from patients with non-small cell lung cancer (NSCLC)| 1991
- 30
-
Topoisomerase gene expression in normal and neoplastic human lung| 1991
- 30
-
Large scale automated sequencing of oncogenes in resectable lung tumours| 1991
- 31
-
Cellular composition of human primary non-small cell lung carcinomas analyzed by immunophenotype and morphology. Purification of tumour cells by flow cytometry| 1991
- 31
-
Variation in the immune system in patient with polmonary carcinomas| 1991
- 31
-
Measurement of cell proliferation in NSCLL cell lines using K167, PCNA and BrdU labelling| 1991
- 31
-
Implication of the β receptor of retinoic acid in epidermoid lung cancer| 1991
- 32
-
Immunohistochemical localization of parathyroid hormone-related protein in bronchial carcinoma| 1991
- 32
-
Role of proteolytic system in lung metastases development at experimental tumors in mice| 1991
- 32
-
Dynamic proliferation assessment of lung cancer with in vivo BrdU labeling and bivariate DNA flowcytometryten Velde, G. / Tinnemans, M. / Lenders, M. / Schutte, B. / Blijham, G. et al. | 1991
- 32
-
A McAb LC-1 which against human lung cancerGe, X.R. / Wang, J. / Lin, S.J. / Che, Y.F. / Li, M. et al. | 1991
- 33
-
Expression of glutathione S-transferase π gene in human lung cancer cell lines| 1991
- 33
-
Value of cytological assessment in determining ability to obtain a karyotype in non-small cell lung cancer (NSCLC)| 1991
- 33
-
Co-amplification of parathyroid hormone-related protein (PTHrP) and C-KI-RAS-2 in a human lung cancer cell line| 1991
- 33
-
Specific chromosome regions involved nonrandomly in cytogenetic abnormalities in primary non-small cell lung cancer (NSCLC)| 1991
- 34
-
The micronucleus assay in the study of the radiosensitivity of human lung cancer cell lines| 1991
- 35
-
TNF-binding sites and TNF in human lung cancerKayser, K / Gabius, H-J / Hagemeyer, O et al. | 1991
- 35
-
Limits and perspectives of surgical resection for non-small cell lung cancerGinsberg, R.J. et al. | 1991
- 35
-
Light and electron microscopic correlation study of pulmonary sclerosing hemangiomas| 1991
- 36
-
Profiling of free plasma amino acids in lung cancer patientsZhang, Pingchang / Chen, Yongzhong et al. | 1991
- 36
-
Biomarkers participate in the interrelationship and dynamic spectrum of lung cancer| 1991
- 36
-
The frequency of lung cancer - an autopsy based study| 1991
- 36
-
Small cell carcinoma of lung. Sex and survival| 1991
- 37
-
Reproducibility of histopathological evaluation in adenocarcinoma of the lungSørensen, J.B. / Hirsch, F.R. / Gazdar, A. / Olsen, J.E. et al. | 1991
- 37
-
Basement membranes (BM) in adenocarcinomas of the lung: an immunohistochemical (IH) and electron-microscopical (EM) studyten Velde, G. / Thunnissen, F. / Dingemans, K. / Wagenaar, S. / Tiebosch, T. / Bosman, F. et al. | 1991
- 37
-
819 primary lung carcinoma cases hospitalized in medical faculty of Ankara University between 1981–1989| 1991
- 37
-
The possibility of clinical application on lung cancer by McAb Lc-1 against human lung cancer through fiberobronscopy biopsy| 1991
- 38
-
Detection of SLX in carcinoma of the lung| 1991
- 38
-
Pathological analysis of Japanese lung cancer in the agedSato, T. / Ito, Y. / Miyaishi, O. / Tauchi, H. / Yamamoto, T. et al. | 1991
- 38
-
Clinical significance of p53 tumor suppressor gene abnormalities in lung cancer| 1991
- 38
-
Familial non small cell bronchogenic carcinoma (NSCLC): A clinic-pathological study of four siblings| 1991
- 39
-
Immunohistochemical study of ADF/hTx expression in associated lymphoid tissue of lung cancer| 1991
- 39
-
Expression of HLA-DR antigen in early squamous cell lung cancersYazawa, T. / Kamma, H. / Ogata, T. et al. | 1991
- 39
-
Expression of HLA-DR antigen in lung cancers and its correlation to histologic types and lymphocytic infiltration| 1991
- 39
-
Leucocyte elastase in lung adenocarcinoma tissueOhshika, Y. / Ozeki, Y. / Kase, K. / Takagi, K. / Kikuchi, K. / Tanaka, S. / Mamiya, G. / Ogata, T. et al. | 1991
- 40
-
Image cytometric DNA analysis in smear specimens of non-small cell lung cancer| 1991
- 40
-
Diagnostic sensitivity and prognostic implications of immunreactive NCAM in small cell lung cancer| 1991
- 40
-
A quantitative study of the frequency of (preneoplastic changes) dysplasia of the respiratory tract in association with non small cell lung cancer| 1991
- 40
-
Pulmonary adenocarcinoma cells DNA content quantitative analysis in effusion| 1991
- 41
-
A morphometric analysis of individual cell death in bronchial carcinoids| 1991
- 41
-
Primary malignant fibrous histiocytoma of the lung| 1991
- 41
-
Immunohistochemical and cytofluorometric analyses of atypical adenomatous hyperplasia of the lungNakayama, H. / Noguchi, M. / Shimosato, Y. / Matsumoto, A. et al. | 1991
- 41
-
Limits and perspectives of irradiation in locally advanced non-small cell lung cancer (NSCLC)Gregor, Anna et al. | 1991
- 41
-
Late BCNU lung: A light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma| 1991
- 42
-
Squamous-cell lung carcinoma in a case of juvenile-onset papillomatosis: Detection of HPV DNA type 11 in benign, metaplastic and malignant lesions by the Polymerase Chain Reaction (PCR)| 1991
- 42
-
Thymic squamous cell carcinoma with secretion of PTH-rP from hepatometastatic tumor and hypercalcemiaMiyake, Maki / Horiuchi, Noriaki / Fujino, Osamu / Oka, Koichi / Ono, Kazuo / Hizawa, Kazuo et al. | 1991
- 42
-
Detection of Human Papillomavirus (HPV) type 16 DNA in squamous--cell carcinoma and adenocarcinoma of the lung using the Polymerase Chain Reaction (PCR)Gaweco, A. / Eberlein-Gonska, M. / Becker, H. / Neimeier, A. / Drings, P. / Otto, H.F. et al. | 1991
- 42
-
Diagnostic value of CEA and TPA in exudative pleural effusionsDe Angelis, G. / Alma, M.G. / Bigioni, D. / Pallotta, G. / Munno, R. / Pigorini, F.C. et al. | 1991
- 43
-
Is DNA image cytometry of sputum specimens a valuable tool for the early detection of lung cancer? Preliminary report of bronchial brushings and aspirates DNA measurementsAssailly, J. / Baldeyrou, P. / Brugal, G. et al. | 1991
- 43
-
Histologic typing of lung cancer in association with exposure to asbestos| 1991
- 43
-
Percutaneous biopsy of parenchymal lung lesions using a biopty gunAllen, CM / Hansell, DH / Sheppard, MN et al. | 1991
- 43
-
Monoclonal antibodies (mabs) for detection of metastatic carcinoma cells in bone marrow of Small Cell Lung Cancer (SCLC)Skov, B.G. / Bobrow, L. / Hirsch, F.R. / England, London. et al. | 1991
- 44
-
Vascular invasion in non small cell lung cancer| 1991
- 44
-
Neuroendocrine differentiation in Non-Small Cell Lung Cancer (NSCLC) (preliminary results)| 1991
- 45
-
Prognostic indicators in lung cancer patients complicated with pleural effusionsShi-Chuan, Chang / Reury-Perng, Perng et al. | 1991
- 45
-
Prognostic significance of mediastinal node level invasion in non small cell lung cancerConill, C / Astudillo, J / Verger, E / Teixidor, J / Solé, J / Serrano, M / Barberá, J / Aguilera, J / Rosell, R et al. | 1991
- 46
-
Immunohistochemical analysis of P-glycoprotein 170 in non-small cell lung cancer| 1991
- 46
-
Multivariate survival analysis of 360 patients with Squamous Cell Lung Cancer (SCLC)FCCP Buccheri, GF. / Ferrigno, D. / Vola, F. / Rosso, A. et al. | 1991
- 46
-
Anti-CEA immunoscintigraphy versus computed tomography (CT) in lung cancer (LC) stagingBuccheri, GF / Biggi, A. / Ferrigno, D. / Leone, A. / D'Angeli, B. / Quaranta, M. / Taviani, M. / Comino, A. et al. | 1991
- 46
-
Long-term survival and prognostic assessment of resected neuroendocrine lung cancer at early stageLequagtle, C. / Cataldo, I. / Preda, F. / Ravasi, G. et al. | 1991
- 47
-
Pre-operative radiation therapy in non-small cell cancer of the lungPayne, David G. et al. | 1991
- 47
-
Nuclear DNA and nuclear protein content in cases with lung adenocarcinomaMD,FCCP Gönüllü, U. / MD Numanoǧlu, N. / MD Alper, D. / MD Savaş, I. / MD Özdemir, Ö. et al. | 1991
- 47
-
Detection of dysplasia and in-situ carcinoma by fluorescence imaging| 1991
- 47
-
Tissue Polipetide Antigen (TPA) has a great prognostic capability in Lung Cancer (LC)FCCP Buccheri, GF. / Ferrigno, D. et al. | 1991
- 47
-
Nutritional status as prognostic factors in lung cancer patients| 1991
- 48
-
Cushing's syndrome associated with ectopic ACTH production and Small Cell Lung Cancer (SCLC)| 1991
- 48
-
Super-long-term survival over 15 years of 128 postoperative patients with lung cancer| 1991
- 48
-
An algorithm for staging patients (PTS) with Small Cell Lung Cancer (SCLC) can save more than 40% of the initial evaluation costs in both the United States and Australia| 1991
- 48
-
New aspects in the staging of lung cancer - validation of the new TNN classification (4th ed.)Drings, P. / Bülzebruck, H. / Danzer, B. / Bauer, E. / Bopp, R. / Krysa, S. / Probst, G. / Vogt-Moykopf, I. et al. | 1991
- 49
-
The prognostic value of monocyte function in patients with small cell lung cancer (SCLC)Hosker, HSR / McArdle, P / Corris, PA et al. | 1991
- 49
-
The prognostic significance of 3 tumour markers (NSE, TPA, SACE) in patients with small cell lung cancerHosker, HSR / Day, J / Jones, GM / Tarbitt, I / Corris, PA et al. | 1991
- 49
-
The nutritional status of patients with small cell lung cancer before and during treatment with chemotherapyHosker, HSR / Jones, GM / Corris, PA et al. | 1991
- 49
-
Undervalued prognostic factors? The possible role of Initial tumor size (ITS) and clinical severity staging (CSS) in stage III NSCLC| 1991
- 50
-
Pericardial effusion as clinical first appearance of non-small cell lung cancer: Prognostic value and therapy| 1991
- 50
-
Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours| 1991
- 50
-
Prognostic significance of cellular DNA content in lung cancer| 1991
- 50
-
Serum sialic acid determination in diagnosis of lung cancer and continuous observation during clinical treatment| 1991
- 51
-
Locoregional staging of lung cancer by endoscopic needle aspiration biopsy| 1991
- 51
-
Adenosquamous carcinoma of the lung: Clinical characteristics and prognosisKunishima, K. / Suyama, M. / Karasawa, K. / Kuwahara, M. / Ariyoshi, Y. et al. | 1991
- 51
-
Four cases of lung cancer with metastasis to the stomachOhtsuka, Hidehiko / Yamada, Minehiko / Shimizu, Susumu / Akizawa, Takanori / Narushima, Michiaki / Tanaka, Kazumasa / Suzuki, Hajime / Noguchi, Eisei et al. | 1991
- 51
-
Cytological diagnosis and DNA content analysis in lung cancer| 1991
- 52
-
Fine needle puncture of carina with fiber-bronchoscopeOhaly, Y / Hillerdal, G et al. | 1991
- 52
-
Clinical significance of flow cytometric nuclear DNA content in non-small cell lung cancer| 1991
- 52
-
Transbronchial aspiration biopsy for determination of the N-factor in lung cancerIshii, M. / Kato, H. / Konaka, C. / Kawate, N. / Yoneyama, K. / Takahashi, H. / Sakai, H. / Okunaka, T. / Miura, H. / Saito, H. et al. | 1991
- 52
-
A prognostic factor risk index in advanced non-small cell lung cancer (NSCLC) treated with combination chemotherapy including cisplatinShinkai, T. / Eguchi, K. / Sasaki, Y. / Tamura, T. / Ohe, Y. / Kojima, A. / Okamoto, H. / Piantadosi, S. / Saijo, N. et al. | 1991
- 53
-
Prognostic factors in patients with small cell lung cancer (SCLC)| 1991
- 53
-
Differentiation and prognosis of lung cancerMukai, Masaki / Kuramishi, Fumito / Yoshioka, Shinkichiro / Nishiki, Masayuki / Dohi, Kiyohiko et al. | 1991
- 53
-
Primary lung cancer (PLC) — Experience with a multidisciplinary approach| 1991
- 53
-
Proposals regarding some deficiencies in the new international staging system for lung cancer| 1991
- 54
-
Clinicopathological study of malignant tumor of the thymus (invasive thymoma, thymic carcinoma and thymic carcinoid)| 1991
- 54
-
Gastrin-releasing peptide (GRP) and progastrin-releasing peptide (PRO-GRP) measured in the plasma of 169 patients with small cell lung cancer (SCLC)| 1991
- 54
-
Epidermal growth factor (EGF) in non-small cell lung cancer — Correlation with survivalIshikuro, Akihiko / Miyamoto, Hiroshi / Akita, Hirotoshi / Haneda, Hitoshi / Fujino, Michihiro / Katou, Masakazu / Kawakami, Yoshikazu et al. | 1991
- 54
-
Cromogranin A, a possible tumor marker in small cell lung cancer| 1991
- 55
-
Pre and post resection pleural cytology in patients undergoing lung resection and mediastinal node mapping for carcinoma| 1991
- 55
-
Natural survival of patients with lung cancer detected during cancer screening in Xuan Wei, China| 1991
- 55
-
Superior vena cava syndrome (SVCS) is a risk factor for brain metastasis in small cell lung cancer (SCLC)| 1991
- 55
-
Tumoral volume and prognosis in limited small-cell lung carcinoma (S.C.L.C.)Baldeyrou, P. / Bouaouina, N. / Arriagada, R. / Ruffie, P. / Le Chevalier, T. et al. | 1991
- 56
-
Comparison of N status as determined by preoperative CT and by intraoperative node mapping in 150 patients undergoing resection for carcinoma of the lung| 1991
- 56
-
Thoracotomy staging of small cell lung cancer| 1991
- 56
-
Flow cytometric (FCM) DNA ploidy in lung cancer| 1991
- 56
-
The impact of neuroendocrine and epithelial differentiation on recurrence and survival in patients with lung cancer| 1991
- 57
-
Mediastinoscopic evaluation of stage IIIA lung cancer: defining a population for pre-operative treatment trials| 1991
- 57
-
Bone marrow (BM) metastases in patients with small cell lung cancer (SCLC) detected by morphological and immunological methods| 1991
- 57
-
Primary staging of carcinoma of the bronchus - is computer tomography of the brain necessary?| 1991
- 57
-
The signification of coagulation and fibrinolytic parameters in patients with lung cancer| 1991
- 57
-
Postoperative radiotherapy for lung cancerVan Houtte, P. et al. | 1991
- 58
-
Effect of prestudy tumor stage and of chemotherapy-radiotherapy (CT-RT) in non-small cell lung cancer (NSCLC)| 1991
- 58
-
Prognostic factors in small cell lung cancer (SCLC). RECPAM analysis on 1,651 pts treated in Copenhagen during 1973 – 1987| 1991
- 58
-
Application of positron emission tomography in the staging of lung cancer| 1991
- 58
-
A multicentre consensus model for prognostic factors in small cell lung carcinoma (SCLC)| 1991
- 59
-
Flow cytometric heterogeneity of primary lung cancer and lymph node metastasesMD Tirindelli Danesi, D. / MD Mecozzi, A. / MD Bangrazi, C. / MD Mancini, M. / MD Modini, C. et al. | 1991
- 59
-
Pre-operative risk evaluation for lung cancer resection| 1991
- 59
-
Prognostic factors for survival in advanced non small cell lung cancer (NSCLC): The experience of the european lung cancer working party. Institut Jules Bordet-Brussels-Belgium| 1991
- 59
-
(SCLC)| 1991
- 60
-
Neuron specific enolases: diagnostic marker for small cell lung cancerStefanovski, T. / Sajkov, D. / Ilievska-Popovska, B. / Spirovski, M. et al. | 1991
- 60
-
The level of carcinoembryonic antigen, tissue proliferative antigen and carbonhydratic antigen 19.9 in serum of patients with different hystological types of lung cancerSajkov, D. / Stefanovski, T. / Ilievska-Poposka, B. / Spirovski, M. et al. | 1991
- 61
-
Pneumothorax CT for the Evaluation of Tumor Invasion of the Chest Wall and the Mediastinum in Lung Cancer| 1991
- 61
-
A study of two anti-carcinoembryonic antigen (CEA) monoclonal antibodies (Mabs) in the immunoscintigraphy of small-cell lung cancer (SCLC)Morgan, D.A.L. / Macmillan, C.H. / Perkins, A.C. / Wastie, M.L. et al. | 1991
- 62
-
Early detection and localization of lung cancerKato, Harubumi / Konaka, Chimori / Okunaka, Tetsuya / Hayata, Yoshihiro et al. | 1991
- 62
-
Usefulness of cine MR imaging in evaluation of cardio-vascular invasion of lung cancers or mediastinal tumors| 1991
- 62
-
In vivo somatostatin receptor imaging in lung cancerKho, G.S. / Krenning, E.P. / Lamberts, S.W.J. / Bakker, W.H. / Oei, H.Y. / Splinter, T.A.W. / Hilvering, C. / Kwekkeboom, D.I. et al. | 1991
- 62
-
Prognostic value of response to chemotherapy using ultrasound in lung cancer with metastatic liver involvementMD Goerg, Christian / MD Schwerk, W.B. / MD Wolf, M. / MD Havemann, K. et al. | 1991
- 63
-
Diagnosis of mediastinal lymph node metastasis of lung cancer with positron emission tomography using 11C-methionineMiyazawa, Hideki / Arai, Takashi / Inagaki, Keizou / Morita, Takatomo / Yano, Makoto et al. | 1991
- 63
-
Clinical usefulness of subtraction CT scan image for lung cancer therapyKato, S. / Asai, T. / Ohno, K. / Ohnuma, N. / Nomura, H. / Nakamoto, T. / Iizuka, M. et al. | 1991
- 63
-
Use of the MAb 3F8 in imaging small-cell lung carcinoma| 1991
- 63
-
Immunoscintigraphy in small cell lung cancer (SCLC): a mouse xenograft tumor study with SC-1 MoAb| 1991
- 64
-
Evaluation of dynamic - table sliding rapid sequence - thin slice computed tomography scan in diagnosis of lymph node metastasis in lung cancer| 1991
- 64
-
Ultrasonographical findings of chest wall tumor in patients with primary and metastatic lung cancerSaito, Hiroyuki / Dambara, Takashi / Muramatsu, Masashi / Obata, Kenichi / Nukiwa, Toshihiro / Kira, Shiro et al. | 1991
- 64
-
Transesophageal color doppler echogram for the assessments of thoracic neoplasms| 1991
- 64
-
Helical scan CT (HS-CT) for detection of peripheral pulmonary nodules (PPN)| 1991
- 65
-
The respective roles of radiation therapy and chemotherapy in non-small cell carcinoma of the lung with mediastinal but not distant metastasis (N2M0)Cox, James D. et al. | 1991
- 65
-
Ultrasonically guided aspiration needle biopsy for the diagnosis of cervical lymph node metastasis from lung cancer| 1991
- 65
-
Mediastinal staging of bronchial carcinoma: Accuracy of computerized tomography and mediastinoscopyKristensen, S / Aaby, C et al. | 1991
- 65
-
Ultrasonographical configuration of thoracic cavities after pleurodesis in patients with malignant pleural effusionObata, Kenichi / Dambara, Takashi / Saito, Hiroyuki / Ueki, Jun / Aiba, Miyoji / Doi, Yoshiyuki / Nukiwa, Toshihiro / Kira, Shiro et al. | 1991
- 65
-
Ultrasonographic approach for diagnosing chest wall invasion of primary lung cancer| 1991
- 66
-
A pathological-radiological study of the tumor-lung margin (TLM) of primary lung cancer| 1991
- 66
-
Early detection of the central endobronchial tumor by a new imaging technique| 1991
- 66
-
Adrenal masses in lung cancer: Sonographic diagnosis and follow-upMD Goerg, Christian / MD Schwerk, W.B. / MD Wolf, M. / MD Havemann, K. et al. | 1991
- 66
-
201T1 uptake ratio is a useful index for tumour doubling time in lung cancerTakekawa, Hironori / Yamazaki, Koichi / Watanabe, Naomi / Sukou, Noriaki / Kunikane, Hiroshi / Ogura, Shigeaki / Abe, Shosaku / Kawakami, Yoshikazu / Ito, Kazuo et al. | 1991
- 67
-
Secondary pulmonary lobule and small peripheral pulmonary carcinoma rentgenologic-pathologic correlative study| 1991
- 67
-
Computerized tomography (CT) for evaluation of response to therapy in small cell lung cancer (SCLC)| 1991
- 67
-
Comparison of amber and high KV chest films in the detection of lung carcinoma| 1991
- 67
-
Usefulness of the esophageal ultrasonography for detection and characterization of hilar and mediastinal lymph nodes invasion by primary lung cancerM.D. Nakajima, J. / M.D. Shindo, G. / M.D. Kubota, H. / M.D. Takeshita, M. / M.D. Furuse, A. et al. | 1991
- 68
-
The radioimmunolocalization of McAb LC-1 and its fragment in nude mice bearing lung adenocacinomaXi-rui, Ge / Shen-nian, Wang / Si-jun, Lin / Rongzeng, Cao / Ming, Li / Jin, Shen / Zhong-yi, Yao / Lingji, Chen / Su-yin, Zhang / Ji-xiao, Ma et al. | 1991
- 68
-
Magnetic resonnance imaging evaluation of bone-marrow involvement in small cell lung cancer: A post- mortem confrontation with autopsic verification in six treated patientsFiche, M. / Rogé, C. / Buhé, T. / Lacroix, H. / Dabouis, G. et al. | 1991
- 68
-
Bone marrow metastases in small cell lung cancer: Evaluation of magnetic resonance imagingBuhé, T. / Fiche, M. / Rogé, C. / Bizais, Y. / Lacroix, H. / Dabouis, G. et al. | 1991
- 68
-
Positron emission tomography for optimized therapy monitoring| 1991
- 69
-
Imaging of human SCLC with radiolabelled monoclonal antibodies against EMBP in a nude mouse model| 1991
- 70
-
Surgical treatment of lung cancer in patients over 60 years of ageChen, DI et al. | 1991
- 70
-
Pathological specialith of bronchial carcinoid and experience of diagnosis and treatmentWu, X. et al. | 1991
- 71
-
The importance of complete resection in the multimodality treatment of SCLCKarrer, K. / Shields, T. et al. | 1991
- 71
-
Surgical adjuvant therapy of non-small-cell lung cancerCarmack Holmes, E. et al. | 1991
- 71
-
Postpneumonectomy space control with SF6Miura, Kazumasa / Tamaki, Hirofumi / Fukumoto, Taizo / Yoshizawa, Kiyoshi / Morita, Junji et al. | 1991
- 71
-
Surgery for malignancy of trachea and main bronchus (report of 21 cases)Lin, Tao-ping / Wu, J.F. / Yang, Y.Y. / Hang, G.T. et al. | 1991
- 71
-
Diagnosis and treatment of small cell lung cancer to discuss and consider Part 2: Treatment| 1991
- 72
-
Follow - up assessment of patients having Nd-Yag laser resection of endo-bronchial lesions| 1991
- 72
-
The management of postpneumonectomy space with sulfur hexafluorid (SF6) gas prevents deterioration of the opposite lung| 1991
- 72
-
Postoperative studies in patients with stage III and IV lung cancerTake, A. / Yamaguchi, T. / Horimi, H. / Murayama, F. / Sohara, Y. / Fukushima, K. / Hasegawa, T. et al. | 1991
- 72
-
Surgery after chemotherapy with continuation of chemotherapy in limited, including N2, small-cell lung cancer: A prospective studyLewiński, T. / Żuławski, M. / Turski, C. / Maryniak, R. / Kozłowicz, I. / Smorczewska, M. / Pietraszek, A. / Kawecki, A. et al. | 1991
- 73
-
Extended operations for T4 primary lung cancerAyabe, H. / Tagawa, Y. / Kawahara, K. / Tomita, M. et al. | 1991
- 73
-
Operative indication of small primary lesion with advanced diseaseShimizu, Junzo / Oda, Makoto / Hayashi, Yoshinobu / Watanabe, Yoh et al. | 1991
- 73
-
Results of surgical treatment for T4 lung cancerOda, Makoto / Watanabe, Yoh / Shimizu, Junzo / Hayashi, Yoshinobu / Ohta, Yasuhiko et al. | 1991
- 73
-
Surgical treatment of primary lung cancer under 40 years old| 1991
- 74
-
The post-operative survival on 1055 cases of stage III lung cancer| 1991
- 74
-
Surgical therapy for apical invading lung cancer by different approaches according to tumor locationNiwa, H / Masaoka, A / Yamakawa, Y / Iizuka, M et al. | 1991
- 74
-
Surgical treatment for small sized (2cm or less in diameter) peripheral type lung cancer lesions| 1991
- 74
-
The risk factor of resected pathological T 1 N 0 M 0 lung cancerDr. Tanaka, Hironori / Dr. Niwa, Hiroshi / Dr. Yamakawa, Yosuke / Prof. Masaoka, Akira et al. | 1991
- 75
-
Significance of extended resection for T3 and T4 lung cancerChiba, W. / Ikeda, S. / Adachi, M. / Yamamoto, Y. / Sawai, S. / Konishi, T. / Matsubara, Y. et al. | 1991
- 75
-
Limited resection for stage I carcinoma of lung| 1991
- 75
-
Systematic bilateral mediastinal dissection and en bloc pulmonary resection through the median sternotomyHata, E. / Miyamoto, H. / Mitoma, Y. / Hayakawa, K. et al. | 1991
- 75
-
Application of the Nd-YAG laser for surgical resection of pulmonary metastases| 1991
- 76
-
The evaluation of surgical treatment of primary lung cancer in the elderlyMizuno, T. / Sano, M. / Kobayashi, T. / Matsui, H. et al. | 1991
- 76
-
Surgical treatment for advanced lung cancer with pleural dissemination| 1991
- 76
-
Simultaneous lung resection and coronary artery reconstruction in patients with lung cancer and ischemic heart diseases| 1991
- 76
-
Radical segmentectomy for X-ray-negative squamous cell carcinoma of the bronchus| 1991
- 77
-
Results of extended operation for advanced lung cancer| 1991
- 77
-
Surgical management of stage II lung cancer| 1991
- 77
-
Sequential chemotherapy and radiotherapy for initial management of Stage IIIA and Stage IIIB non-small cell lung cancer — induction chemotherapyGreen, Mark R. et al. | 1991
- 77
-
Flap resection of lateral wall of trachea, carina, and bronchus for carina invasive lung cancerMitsui, K. / Akaogi, E. / Onizuka, M. / Morita, R. / Ishikawa, S. / Kinoshita, T. / Yamamoto, T. / Ishibashi, O. / Ogata, T. / Hori, M. et al. | 1991
- 77
-
Surgery for lung cancer invading the chest wall| 1991
- 78
-
Actuarial 5-yr. survival after resection of N 2 lung cancer| 1991
- 78
-
Primary lung cancer in young adults under 40 years oldMaruyama, Shuichiro / Ando, Akio / Date, Hiroshi / Shimizu, Nobuyoshi / Teramoto, Shigeru et al. | 1991
- 78
-
Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer| 1991
- 78
-
The “kergin” pneumonectomy| 1991
- 79
-
Bronchoplastic and tracheobronchoplastic procedures for lung cancer| 1991
- 79
-
Clinical apsect of early hilar lung cancerWatanabe, Y. / Shimizu, J. / Oda, M. / Hayashi, Y. / Ikegaki, S. / Takashima, T. / Kamimura, R. / Nonomura, S. et al. | 1991
- 79
-
Necessity of mediastinal lymph nodes dissection in operable lung cancer (a randomized study)| 1991
- 79
-
T4 (trachea-heart-great vessels) lung cancer surgery| 1991
- 80
-
Surgical resection for T4 tumor in non-small cell lung cancer| 1991
- 80
-
Closure of the bronchial stump fistula with fibrin sealentOrłowski, T.M. / Oudek, K. / Kaleta, M. et al. | 1991
- 80
-
Treatment of small cell lung cancerLi, Zejian / Ren, Hua / Zhang, Zhiyong / Sun, Chengfu / Xu, Letian / Yu, Hongquan / Li, Longyun / Zhou, Juechu / Yan, Hongzhen / Liu, Hongrui et al. | 1991
- 80
-
Stenting of the tracheo-bronchial treeOrłowski, Tadeusz M. et al. | 1991
- 81
-
Palliative endobronchial laser-resection. Its role in multimodal treatment of advanced lung cancer| 1991
- 81
-
Conbined resection in lung cancer and intraoperative echogramTatsumura, T. / Kasazima, M. / Koyama, S. / Sugiyama, S. / Tsujimoto, M. / Nishide, R. / Furuno, T. / Yamamoto, K. et al. | 1991
- 81
-
The role of tracheobronchoplasty for extensive and limited operation against lung cancer| 1991
- 81
-
Autologous blood transfusion for operation of the lung cancerWatanabe, M. / Niwa, Y. / Kobayashi, T. / Kawamura, M. / Kato, R. / Kikuchi, K. / Kobayashi, K. / Ishihara, T. et al. | 1991
- 82
-
The role of limited lung resection for bronchogenic carcinomaPrakash, D. / Al-Jilaihawi, A.N. / Ogunnaike, H. et al. | 1991
- 82
-
Most peripheral, node-negative non-small cell lung cancer (NSCLC) have absence of intra- and peritumoral blood and lymphatic vessel invasion and low proliferative rates, which provides a rationale for treatment with wedge resection (WR) alone| 1991
- 82
-
Right pneumonectomy and carinal reconstruction in anterior thoracotomy for lung cancer| 1991
- 82
-
Late appearance of malignancies after surgery for TI no non-small cell lung cancer| 1991
- 83
-
Long-term postthoracotomy pain| 1991
- 83
-
The application of microwave therapy on cases with late thoracic malignant tumor — 16 cases reportChen Di et al. | 1991
- 83
-
Patients with T1 N0 non-SCLC lung cancerM.D. Ginsberg, Robert J. / Ph.D. Rubinstein, Lawrence et al. | 1991
- 83
-
Feasibility of surgery after chemotherapy (CT)| 1991
- 84
-
Thoracoscopy: Its evaluation as method of selection in the etyological diagnosis of the pleural pathologyPire, R. / Galvez, C. / Bonamassa, M.A. et al. | 1991
- 84
-
Pancoast's tumor: results of combined treatment (irradiation and radical resection)Rea, F. / Sartori, F. / Calabró, F. / Mazzucco, C. / Bortolotti, L. / Tomio, L. et al. | 1991
- 84
-
Patient controlled analgesia (PCA) in the management of thoracotomy patients| 1991
- 84
-
Sleeve lobectomy for lung cancerRea, F. / Sartori, F. / Calabró, F. / Loy, M. / Erroi, L. / Bortolotti, L. / Toniolo, L. et al. | 1991
- 85
-
Postoperative complications after thoracotomy for lung cancer in the elderlyFiacchi, M / Di Gaetano, P / Grazia, M / Bini, A / Bazzocchi, R et al. | 1991
- 85
-
Limited resection for stage I lung cancerPastorino, Ugo / Valente, Maurizio / Bedini, Vittorio / Infante, Maurizio / Tavecchio, Luca / Gherardini, Giulio / M.D. Ravasi, Gianluigi et al. | 1991
- 85
-
Combined radiotherapy with chemotherapy for inoperable non-small cell lung cancerBleehen, Norman M. et al. | 1991
- 85
-
Segmentectomy, wedge resection and lobectomy for non small cell lung cancerGotti, G. / Paladini, P. / Maccherini, M. / Haid, M. / Di Bisceglie, M. / Lisi, G. / Biagi, G. et al. | 1991
- 85
-
Resectable N2 disease according to the predicted location of enlarged mediastinal nodesValente, M / Musumeci, R / Tavecchio, L / Muscolino, G / Pastorino, U / Bedini, AV / Ravasi, G et al. | 1991
- 86
-
Nenagnent of NSCLC at stage III. Past experienceMD Modini, C. / MD Tirindelli Danesi, D. / MD Cicconetti, F. / MD Mancini, M. / MD Necozzi, A. / MD, FACS Stipa, S. et al. | 1991
- 86
-
Palliative resection of massive pleural metastases from extrathoracic sarcomas — (MPMES)| 1991
- 86
-
Role of surgery for isolated cerebral metastasis in patients with resectable non-small cell lung cancer| 1991
- 86
-
The survival in different N2 site infiltration in patients operated on for lung cancerGotti, G. / Paladini, P. / Maccherini, M. / Haid, M. / Di Bisceglie, M. / Miraldi, F. / Biagi, G. et al. | 1991
- 87
-
Lung function after irradiation in patients with lung cancer and borderline lung functionsAbratt, RP / Willcox, PA / Smith, JA et al. | 1991
- 87
-
Endobronchial chemotherapy (EBCH) in combined NSCLC treatmentCicénas, S / Aleknavičius, E / Valuckas, K et al. | 1991
- 88
-
The application of microwave therapy on cases with late thoracic malignant tumor — 16 cases| 1991
- 88
-
Combination of radiation and iriquinone (Iq7611) in the treatment of lung carcinomaLi, Wei-lian / Niu, Zhao-lin / Chang, Li et al. | 1991
- 89
-
Prospective randomised trial of palliative radiotherapy (RT) given in two fractions (F2) or one fraction (F1) for patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status| 1991
- 89
-
Radiotherapeutic palliation of spinal epidural compression in small cell lung cancer| 1991
- 89
-
Postoperative radiation therapy in non-small cell lung cancerEmemi, B. / Kaiser, L. / Simpson, J. / Shapiro, S. / Roper, C. / Lockett, M.A. et al. | 1991
- 89
-
High dose conventional fractionation radiation therapy in unresectable non-small cell lung cancer: Patients with good prognostic factorsM.D. Ememi, B. / M.D. Graham, M.L. / Lockett, M.A. et al. | 1991
- 90
-
The influence of various split durations on survival in radical split-course radiotherapy in nonsmall cell lung cancer (NSCLC) patients| 1991
- 90
-
Brachytherapy in patients with recurrences after external irradiation: A phase II study| 1991
- 90
-
The impact of individual computerised treatment planning on the results in bronchogenic carcinomas| 1991
- 90
-
Single dose prophylactic cranial irradiation (PCI) for small cell lung cancer (SCLC)Stout, R. / Burt, P.A. / Thatcher, N. et al. | 1991
- 91
-
Assessment of late radiation damage in inoperable bronchial carcinoma patients treated by radical radiotherapy| 1991
- 91
-
Treatment results of non-resectable lung cancer: Radiation alone versus combined radiochemotherapy| 1991
- 91
-
Ga-67 scintigraphy for detection of recurrent lung cancer following radiotherapyNakayama, Y. / Hayakawa, K. / Mitsuhashi, N. / Tsuchiya, M. / Niibe, H. et al. | 1991
- 91
-
Response rate as criterium to evaluate chemotherapy in non-small cell lung cancerSplinter, Ted A.W. et al. | 1991
- 91
-
Endobronchial radiotherapy as palliation in patients with central airway malignanciesHelle, P.A. / Slingerland, R. / van der Sangen, M.J.C. / Heysteeg, M. / Levendag, P.C. / Koper, P.C.M. et al. | 1991
- 92
-
Prediction of radiotherapeutic effectiveness for inoperable primary lung cancer based on multi-variate analysis of CT criteriaEndow, M. / Suzuki, H. / Nakashima, Y. / Ishikawa, T. / Saeki, S. et al. | 1991
- 92
-
Elective brain irradiation (EBI) in small cell lung cancer (SCLC)| 1991
- 92
-
Radical radiotherapy in stage I–III epidermoid carcinoma of the lung| 1991
- 92
-
Fast neutron radiotherapy for non-small cell lung cancer: Results of NTCWG randomized trial 85-24Ph.D., M.D Laramore, G.E. / Ph.D. Krall, J.M. / M.D. Maor, M.H. / M.D. Griffin, T.W. / M.D. Burnison, M. / M.D. Taylor, M.E. / M.D. Davis, L.W. et al. | 1991
- 93
-
Concomitant chemotherapy and radiotherapy in advanced lung cancer. A randomized studyPetriz, L. / Arellano, A. / Ballester, R. / Galiana, R. / Cambray, M. / Arnaiz, M. / Gutierrez, C. / Pera, J. et al. | 1991
- 93
-
Primary carcinoma of the tracheaDar, A.R. / Dr. Springer, C. et al. | 1991
- 93
-
Changes of type III procollagen N-terminal peptide (P-III-P), prolylhydroxylase (PH), and laminin P1 levels after radiotherapy of lung cancer| 1991
- 93
-
The role of radiotherapy in small cell lung carcinoma (SCLC) limited disease. Experience in our departmentPetriz, L / Ballester, R. / Haddad, J. / Martinez Ferri, F. / Lozano, A. / Cambra, M.J. / Pera, J. et al. | 1991
- 94
-
Post-operative radiotherapy in non small cell lung carcinoma: Ten years of experience and definitive results| 1991
- 94
-
Radiotherapy planning of lung cancer using CT simulation systemM.D. Kusima, Takeyuki / M.D. Imanaka, Kazufumi / M.D. Kono, Michio et al. | 1991
- 94
-
Optimizing the role of radiotherapy in the treatment of limited stage small cell lung cancer (LSCLC)| 1991
- 94
-
Small cell lung cancer (SCLC) negative results of a randomized clinical trial on delayed thoracic radiotherapy administered to complete responders (CR) patients| 1991
- 95
-
Endobronchial radiotherapy for malignant bronchial obstruction or recurrence| 1991
- 95
-
Brain metastasis in patients treated by surgery and adjuvant radiotherapy for non small cell lung carcinoma: Incidence, radiotherapy and analysis of the results| 1991
- 95
-
Intraluminal irradiation of obstructing bronchial tumours. Clinical results, survival and outcome| 1991
- 95
-
The competing risk approach in determining relapse-free survival in limited small cell lung carcinoma| 1991
- 96
-
Metastatic spinal cord compression secondary to lung cancer| 1991
- 96
-
Primary tumour volume as prognostic factor for bronchial carcinoma| 1991
- 96
-
Does postoperative irradiation affect pulmonary function in patients with Non-Small Cell Lung Cancer (NSLC)?| 1991
- 96
-
Treatment and planning decisions in non-small cell carcinoma of the lung - An Australasian patterns of practice study| 1991
- 97
-
Postoperative radiotherapy after pneumectomy for lung cancers impact of modern treatment facilitiesPhlips, P. / Rocmans, P. / Vanderhoeft, P. / Van Houtte, P. et al. | 1991
- 97
-
Does preoperative RF capacitive hyperthermia combined with radiotherapy increase survival rate in advanced lung cancer?| 1991
- 97
-
Postoperative radiotherapy for locally advanced lung cancers: Importance of mediastinal involvement on treatment outcome| 1991
- 97
-
High dose rate endobronchial brachytherapy using the microselectronGrafton, C. / Lam, S. / Voss, N. / Fairey, R. / Goddard, K. / Yuen, K. et al. | 1991
- 98
-
Influence of radiotherapy (Rt) on blood histamine of patients with Non-Small Cell Lung Cancer (NSCLC)Teixeira, E. / Julio, I. / Sotto-Mayor, R. / Azevedo, M.S. / Maçanita, J. / Bugalho de Almeida, A. / Manso, C. / Freitas e Costa, M. et al. | 1991
- 98
-
Meta-analysis of randomized trials evaluating the role of thoracic radiotherapy in limited small cell lung carcinoma (SCLC)| 1991
- 98
-
Long term palliation of advanced tracheobronchial tumors by HDR brachytherapy in the interdisciplinary conceptvan Bodegom, P.C. / Becker, H.D. / Fritz, P. / Schraube, P. / Drings, P. / Wannenmacher, M. / Vogt-Moykops, I. et al. | 1991
- 98
-
Efficacy of radiotherapy in 79 patients with brain metastases from primary lung cancer| 1991
- 99
-
Non-conventional fractionated radiotherapy in the treatment of patients with non small cell lung cancer| 1991
- 99
-
Longer survival with higher doses of thoracic radiotherapy in non small cell lung cancer (NSCLC)Ball, D / Matthews, J / Worotniuk, V / Crennan, E et al. | 1991
- 99
-
Surgery (S) vs surgery + radiotherapy (S+RT) in T2 - N1–2 non small cell lung carcinoma (NSCLC). An analysis of mean term data| 1991
- 99
-
Prospective study confronting wide field RT versus strictly involved in the management of non-small lung cancer. An analysis of early locoregional failures and toxicityGramaglia, A. / Milani, F. / Basso Ricci, S. / Villa, S. / Bedini, A.V. / Ravasi, G. et al. | 1991
- 100
-
Laboratory research on the opening of the blood-brain barrier with veinous drip of mannitolFuyi, Xing et al. | 1991
- 100
-
HD-DDP plus VP-16 in the treatment of advanced lung cancer — Report of 89 patientsXie Qiufang / Xiong Hui / Sun Yan / He Yan et al. | 1991
- 101
-
Combination chemotherapy and cytokines in the treatment of advanced primary lung cancer: Controlled clinical trial three year results| 1991
- 101
-
Etoposide scheduling in combination chemotherapy for limited disease small cell carcinoma — A prospective studyAbratt, RP / Jansen, ER / Salton, DGM et al. | 1991
- 101
-
Utility of the chemotherapy in advanced non small cell lung cancer (NSCLC): Results of a meta-analysisSouquet, P.J. / Boissel, J.P. / Bernard, J.P. et al. | 1991
- 101
-
A clinical research on treatment of nonoperative lung carcinoma with multiple cerebral metastasis by chemical drugs treatmentFuyi, Xing et al. | 1991
- 102
-
Randomized trial of carboplatin (CBDCA) and etoposide (E) administered either IV in a three-day schedule or in a protracted oral mode in non-small cell lung cancer (NSCLC)| 1991
- 102
-
Carboplatin, vinblastin and mitomycin (CMV) in advanced and disseminated non small cell lung cancer (NSCLC)Souquet, P.J. / Fournel, P. / Glot et al. | 1991
- 102
-
Efficacity of carboplatin in brain metastasis of lung cancerVelay, B. et al. | 1991
- 102
-
Single agent oral etoposide in advanced NSCLC (chronic daily) and in elderly patients with SCLCGatzemeier, U. / Neuhauss, R. / Heckmayr, M. et al. | 1991
- 103
-
Lonidamine (LND) vs mitomycin/vindesine (MV) vs MV + LND in extensive stage non-small-cell lung cancer (NSCLC) — A prospective randomized phase III-TrialGatzemeier, U. / Neuhauss, R. / Koschel, G. / Kaukel, K. / Häussinger, H. / Pawel, J.v. / Cavalli, E. / Martinelli, G. et al. | 1991
- 103
-
A phase II-trial wiht sulofenur in advanced NSCLCGatzemeier, U. / Neuhauss, R. / Drings, P. / Manegold, C. et al. | 1991
- 103
-
Prospective randomised trial of 3 or 6 courses of etoposide cyclophosphamide methotrexate and vincristine and of 6 courses of etoposide and ifosfamide in small-cell lung cancer (SCLC)| 1991
- 103
-
Chemotherapy of patients with extensive stage small-cell lung cancer with carboplatin/etoposide/vincristin (CEV) vs. etoposide/vincristine (EV) a phase III trialGatzemeier, U. / Neuhauss, R. / Pawel, J.v. / Laumen, R. / Hossfeld, D.K. et al. | 1991
- 104
-
Adriamycin(A), cyclophosphamide(CY), nitrogen mustard(M), 5-fluorouracil(F), cis platinum(P) and lomustine(L), in non small cell lung cancer (NSCLC)| 1991
- 104
-
Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant” surgery for limited small cell lung cancer (SCLC)Gridelli, C. / Maiorino, A. / Curcio, C. / D'Aprile, M. / Ianniello, G. / Brancaccio, C. / Palmeri, S. / Gentile, M. / Comella, G. / Pedicini, T. et al. | 1991
- 104
-
Chemotherapy with MACC and lonidamine (LND) in unresectable NSCLC: A phase II study| 1991
- 104
-
Phase II study of mitomycin C, etoposide and vindesine in stage IV non small cell lung cancer (NSCLC)| 1991
- 105
-
A novel regimen for the treatment of small cell lung cancer SCLC in the elderly| 1991
- 105
-
Chemotherapy for locally advanced (Stage III) non-small cell lung cancerKlastersky, Jean / Nemec, Jaroslav et al. | 1991
- 105
-
Weekly-divided cisplatin for extensive non-small cell lung cancer| 1991
- 105
-
Phase II study of carboplatin + etoposide + epirubicin (CEE) in small cell lung cancerSantomaggio, C. / Di Vincenzo, M. / Labardi, C. / Lopes Pegna, A. / Nutini, S. / Righi, R. / Romagnoli, E. et al. | 1991
- 105
-
Lonidamine, chemotherapy (cisplatin and etoposide) and chemotherapy plus lonidamine vs the best supportive care in the treatment of advanced non small cell lung cancer (NSCLC). Preliminary results of a randomized studyGasparini, S. / Farabollini, B. / Isidori, P. / Pinsero, G. / Raspugli, M. / Rossi, A. / Ugolini, M. / Massei, V. et al. | 1991
- 106
-
Treatment of small cell lung cancer (SCLC) in the elderly| 1991
- 106
-
Treatment of recurrent small lung cancer after CR with vindesine, ifosfamide and etoposidePawel, J.v. / Faderl, B. / Gatzemeier, U. / Laumen, L. / Schröder, U. et al. | 1991
- 106
-
A randomised trial of granulocyte colony stimulating factor (G) in patients with small cell lung cancer (SCLC)| 1991
- 106
-
Phase III studies in the therapy of small cell lung cancer (SCLC): A North Central Cancer Treatment Group (NCCTG) trial| 1991
- 107
-
Treatment of non-small cell lung cancer (NSCLC) with ifosfamide (IF) + 4 epiadriamycin (4 EPI) + platinum (P) vs IF + 4 EPIBrocato, N. / Bruno, M. / Araujo, C. / Temperley, G. / Cervellino, J. / Sparrow, C. / Savulsky, C. / Balbiani, L. et al. | 1991
- 107
-
Cisplatin dose intensity in metastatic non-small cell cell lung cancer: Results of a phase III comparative study| 1991
- 107
-
Phase III trial of cisplatin, vinblastin (VP) vs cisplatin, vinblastin, ifosfamide (VIP) for non-operable non-small lung cancer (NSCLC)| 1991
- 107
-
Randomised trial of oral verapamil with chemotherapy for non-small cell lung cancer (NSCLC)Millward, M.J. / Munro, N. / Cantwell, B.M.J. / Harris, A.L. / Corris, P. et al. | 1991
- 108
-
Phase I trial of chloroquinoxaline sulfonamide (CQS): A unique agent with activity in NSCLC selected for study based on activity in an in vitro stem cell assay| 1991
- 108
-
Potentially synergic effect of combined treatment (chemotherapy+lonidamina+radiotherapy) in inoperable NSCLC| 1991
- 108
-
Immunohistochemical detection of CEA and P-glycoprotein (P-gp) in small cell lung cancer (SCLC): With special reference to the tissue expression of CEA and response to chemotherapy| 1991
- 108
-
Ifosfamide, epirubicin and cisplatin (IEP) — Another active combination for small cell lung cancer (SCLC)Thongprasert, Sumitra / Jiemsriponges, Kriengsak / Phothiratana, Chaicharn / Atikachai, Budsaba et al. | 1991
- 109
-
Quantifying the quality survival time for patients with advanced non-small cell lung cancer (NSCLC) treated with the code regimen| 1991
- 109
-
Iphosphamide(IF) + 4 epidoxorubicin(4EPI) + Vpl6 in the treatment of inoperable small cell lung cancerTemperley, GJ / Balbiani, L / Brocato, N / Sparrow, C / Bruno, M / Savulsky, C / Cervellino, J / Pirisi, C / Araujo, C. et al. | 1991
- 109
-
Phase II study of ifosfamide (IFX), cisplatin (CDDP) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC)| 1991
- 109
-
High dose combined alkylating agents with autologous bone marrow support (ABMT) followed by consolidative radiotherapy for responding small cell lung cancer (SCLC)| 1991
- 110
-
Phase II trials in small cell lung carcinoma (SCLC) 1970–1990. The case for entering previously treated patients| 1991
- 110
-
Comparison of in vitro cytotoxicity between cisplatin and carboplatin in human non-small cell lung cancer lines| 1991
- 110
-
Randomized trial of cisplatin(CDDP) plus ifosfamide(IFM) versus CDDP plus vindesine(VDS) for non small cell lung cancer(NSCLC)| 1991
- 110
-
Phase I study of high dose cisplatin, ifosfamide and VP-16 (VIPP) in advanced non-small cell lung cancer (NSCLC)| 1991
- 111
-
Long term survival analysis of stage III & IV non-small cell lung cancer patients (Pts) treated with edatrexate (ETX, 10-Edam)| 1991
- 111
-
Phase II trial of high dose epirubicin and ifosfamide in advanced non small cell lung cancer (NSCLC)| 1991
- 111
-
A prospective study of low dose oral etoposide in poor prognosis small cell lung cancer (SCLC)| 1991
- 111
-
Randomized study comparing cisplatin(CDDP) and vindesine(VDS) combination(PV) and CDDP, VDS and ifosfamide(IFX) combination(PVI) in non-small cell lung cancer (NSCLC)| 1991
- 112
-
A phase II study with continuous infusion cisplatin (CDDP) plus 5-fluorouracil (5-FU) in advanced non-small cell lung cancer (NSCLC)Tsuchiya, S. / Minato, K. / Nakano, H. / Fuekl, N. / Hoshino, H. / Takise, A. / Ezawa, K. / Takel, Y. / Naruse, I. / Nomoto, T. et al. | 1991
- 112
-
Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer| 1991
- 112
-
Correlation between total dose of cisplatin and vibratory perception threshold in chemotherapy-induced neuropathy of lung cancer patientsOshita, Fumihiro / Ohmatsu, Hironobu / Karato, Atsuya / Okamoto, Hiroaki / Kojima, Akira / Ohe, Yuichiro / Tamura, Tomohide / Sasaki, Yasutsuna / Eguchi, Kenji / Shinkai, Tetsu et al. | 1991
- 112
-
Pharmacokinetics with a 5 day continuous infusion of a camptothecin derivative, CPT-11| 1991
- 113
-
Experience of angiotensin - and OK-432 - induced hypertension - hyperthermo - immunochemotherapy for lung carcinoma| 1991
- 113
-
Phase II study of whole peptidoglycan (WPG) for malignant pleural effusionImamura, F. / Ikegami, H. / Niitani, H. et al. | 1991
- 113
-
A phase I study of CPT-11 in combination with vindesine and cisplatin in advanced non-small cell lung cancer| 1991
- 113
-
Combined use of BAI and systemic chemotherapy for the treatment of atelectasis in advanced non-small cell lung cancer (NSCLC)| 1991
- 113
-
New drugs in the treatment of non-small cell lung cancerEttinger, David S. et al. | 1991
- 114
-
Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy| 1991
- 114
-
Randomised clinical study of verapamil in addition to chemotherapy in small cell lung cancer (SCLC)| 1991
- 114
-
Two high-dose epirubicin studies in untreated poorer prognosis small cell lung cancer (SCLC)| 1991
- 114
-
Malignant atypical carcinoid of the lung: Is chemotherapy the answer?| 1991
- 115
-
Prospective study of postoperative adjuvant chemotherapy with or without OK-432 for resected non-small cell lung cancer -interim report-| 1991
- 115
-
Randomised trial of cyclophosphamide, doxorubicin, vincristine (CAV) versus ifosfamide, etoposide (IE) in small cell lung cancer (SCLC)| 1991
- 115
-
Phase II study of 120 hour-continuous infusion of cisplatin (P) and etoposide (E) in untreated small cell lung cancer (SCLC)| 1991
- 115
-
Ifosfamide (I), Carboplatin (C) and Etoposide (E) for ‘good prognosis’ small cell lung cancer| 1991
- 116
-
Phase II trial of etoposide and split-dose cisplatin and pirarubicin (THP) in small cell lung cancer (SCLC)Matsui, Yusaku / Kado, Masao / Izumi, Takateru et al. | 1991
- 116
-
Effect of chemotherapy on colony forming unit-granulocyte macrophage (CFU-GM) in bone marrow and blood of lung cancer patients| 1991
- 116
-
Alternating chemotherapy of cyclophosphamide + adriamycin + vincristine(CAV)--cisplatin + etoposide(PVP) for small cell lung cancer| 1991
- 116
-
Recombinant human granulocyte-macrophage colony stimulating factor significantly reduces the myelosuppression of intensive combination chemotherapy in patients with small cell lung cancer - a randomised double-blind placebo-controlled study| 1991
- 117
-
Phase II study of concurrent cisplatin(C), vindesine (V), mitomycin-C(M) chemotherapy plus split course radiotherapy (RT) for inoperable locally advanced non-small cell lung cancer (NSCLC)| 1991
- 117
-
Prospective trial of weekly alternating chemotherapy in extensive small cell lung cancer| 1991
- 117
-
Randomized study on the usefulness of etoposide, UFT, Ubenimex as a postoperative adjuvant chemotherapy for non-small cell lung cancerShimizu, N. / Ando, A. / Teramoto, S. / Ono, K. / Nakajima, Y. / Saeki, H. / Konishi, H. / Higashi, R. / Sugata, H. / Nagao, T. et al. | 1991
- 117
-
A late phase II study of navelbine (vinorelbine), a new vinca alkaloid derivative, in non small cell lung cancerKubota, K. / Furuse, K. / Niitani, H. et al. | 1991
- 118
-
Chronic daily administration of oral etoposide and cisplatin for advanced non-small cell lung cancer (NSCLC)| 1991
- 118
-
Platino+vindesine(PV) vs PV+lonidamine(L) in non small cell lung cancer(NSCLC). Preliminary results of a randomized studyContu, A. / Olmeo, N. / Ortu, S. / Deriu, A. / Scanu, AC. / Piro, S. / Schintu, G.M. / Bechere, M. / Piras, M. / Pusceddu, G. et al. | 1991
- 118
-
Comparison of chronic oral and intravenous etoposide administration in comdination with cisplatin for the treatment of small cell lung cancer| 1991
- 118
-
Lonidamine combined with cyclofosfamide in treatment of advanced bronchogenic non-small cell carcinoma: Intermediate results of a phase II study in elderly patients| 1991
- 119
-
Fotemustine: French multicenter phase II study in 67 patients with advanced non small cell lung carcinoma (NSCLC)Monnier, A. / Pujol, J.L. / Cerinna, M.L. / Riviere, A. / Douillard, J.Y. / Gouva, S. / Benoliel, C. / Berille, J. / Le Cesne, A. / Le Chevalier, T. et al. | 1991
- 119
-
The effect of suramin on human lung cancer cell line in vitroFujiuchi, S. / Tsuji, T. / Onodera, S. / Ishida, S. / Fujikane, T. / Shimizu, T. et al. | 1991
- 119
-
Augmentation of CDDP cytotoxicity by amphotericin B in CDDP resistant human lung cancer cell lines in vitro and in vivo| 1991
- 119
-
Phase II pilot study of fotemustine - cisplatin combination in 24 patients with advanced non small cell lung carcinomaRiviere, A. / Le Cesne, A / Benoliel, C. / Berille, J. / Le Chevalier, T. et al. | 1991
- 120
-
Detection and characterization of nuclear proteins that recognize cisplatin-damaged DNA in human lung cancer cell lines| 1991
- 120
-
Mechanism of cisplatin(CDDP) and platinum derivatives resistance in non-small cell lung cancer cell line(PC-14/CDDP) and its circumvention by tetrachloro (D,L-trans) 1,2-diaminocyclohexaneplatinum(IV) (tetraplatin)| 1991
- 120
-
Increased phosphorylation of nuclear phosphoproteins in human lung cancer cells resistant to cisplatin| 1991
- 120
-
Prospective analysis of prediction from creatine clearance (Ccr.) of thrombocytopenia in patients with (glycolato-O,O′)-diammine platinum (II) (254-S), a new platinum complex, in clinical phase II study| 1991
- 121
-
Etoposide and teniposide in untreated small cell lung cancer (SCLC)| 1991
- 121
-
A three-armed randomized trial in small cell lung cancer (SCLC) of two induction regimens with teniposide and cisplatin or carboplatin followed by alternating chemotherapy versus alternating chemotherapy| 1991
- 121
-
Combination chemotherapy with cisplatin, ifosfamide and etoposide for small cell lung cancer| 1991
- 121
-
Phase II study of gemcitabine in non small cell lung cancer (NSCLC)| 1991
- 122
-
Results of postoperative intrathoracic chemothermotherapy (PICT) for locally advanced lung cancer with carcinomatous pleuritis| 1991
- 122
-
Fractionated high doses (HD) of epirubicin (E) in adenocarcinoma of the lung (ADL)Villar, A. / Antón, E. / Jimeno, J. / Aranda, E. / Balaña, C. / Massuti, B. / Lizón, J. / Carrato, A. / Belón, J. / Candel, MT. et al. | 1991
- 122
-
In vivo activity and pharmacokinetic analysis by 19F-magnetic resonance spectroscopy (FMRS) of 2′2′difluorodeoxycyticine (DFDC, gemcitabine) in small cell lung cancer (SCLC) xenograftsKristjansen, PEG / Quistorff, B / Spang-Thomsen, M / Hansen, HH et al. | 1991
- 122
-
A randomized comparative study of 254-S/vindesine (VDS) vs. cisplatin (CDDP)/VDS for advanced non-small cell lung cancer (NSCLC)| 1991
- 123
-
CPT-11, a new derivative of camptothecin, for patients with previously treated small cell lung cancer (SCLC)| 1991
- 123
-
Double masking study of Ubenimex (bestatin) on squamous cell lung cancerNakagawa, Kazuhiko / Fukuoka, Masahiro / Genka, Keiichiro / Sakuma, Akira / Niitani, Hisanobu et al. | 1991
- 123
-
Dose intensive weekly code chemotherapy (CT) with or without recombinant human granulocyte colony-stimulating factor (rhG-CSF) in extensive-stage (ES) small cell lung cancer (SCLC)| 1991
- 123
-
Biologicals in the therapy of lung cancerStahel, Rolf A. et al. | 1991
- 124
-
Alternative 6 drug combination chemotherapy consisted of (A): cisplatinum(CDDP)+etoposide(EP)+ vincristine(VCR) and (B): cyclophosphamide(CPM)+ adriamycin(ADM)+methotrexate(MTX) in small cell lung cancer(SCLC)Saito, J. / Koinumaru, S. / Tsukamoto, T. / Nakai, Y. et al. | 1991
- 124
-
Synergistic effects of CPT-11 and cisplatin or etoposide on human lung cancer cell lines demonstrated by computer analysis| 1991
- 124
-
Assessment of postoperative adjuvant chemotherapy on non-small cell lung cancer| 1991
- 124
-
Chemotherapy versus chemo-BRM therapy in adenocarcinoma of the lung: In relation to quality of lifeNakai, Y. / Koinumaru, S. / Saito, J. / Fukuoka, M. / Kobayashi, K. / Gemma, A. / Niitani, H. / Ogawa, N. / Kimura, K. / Nishiwaki, Y. et al. | 1991
- 125
-
Cisplatin, etoposide and mitomycin (CVM) or adriamycin (CVA) in non-small cell lung cancer. (NSCLC)| 1991
- 125
-
Phase II study of zeniplatin, an active new agent in advanced non-small cell lung cancer (NSCLC)| 1991
- 125
-
Preliminary report of a randomized multi-center controlled study of immuno-chemotherapy versus chemotherapy in small cell lung cancerHayasaka, S. / Yoshinaga, K. / Kinuwaki, E. / Fukuoka, M. / Furuse, K. / Kawahara, M. / Kubota, K. / Ogawa, N. / Nishikawa, H. / Uchiyama, T. et al. | 1991
- 125
-
Phase II study of CPT-11, new camptothecin derivative, in previously untreated non-small cell lung cancer (NSCLC)| 1991
- 126
-
Role of leucovorin (LV) for edatrexate (E), cyclophosphamide (C) and cisplatin (P) regimen| 1991
- 126
-
A randomised trial comparing a low toxicity regimen (carboplatin, vinblastine & methotrexate (CVM) against adriamycin, cyclophosphamide & etoposide in small cell lung cancer (SCLC)| 1991
- 126
-
Etoposide and high dose carboplatin in previously untreated patients with small cell lung cancer (SCLC)| 1991
- 126
-
Augmentation of cytotoxicity of chemotherapy by cytokines in non small cell lung cancer. A randomized phase II study| 1991
- 127
-
Dose intensity (DI) of the CAVE regimen in SCLC is important for achieving a higher response rate (R)Sirzea, F. / Lewensohn, R. / Westerberg, R. et al. | 1991
- 127
-
Natural alpha interferon as maintenance therapy for small cell lung cancerMattson, K / Niiranen, A / Holsti, LR / Holsti, P / Pyrhönen, S / Kumpulainen, E / Numminen, S / Cantell, K et al. | 1991
- 127
-
Extended administration of oral cyclophosphamide (C) and oral etoposide (E) for the treatment of stage IV non-small cell lung cancer - A southwest oncology group study| 1991
- 128
-
MIC chemotherapy in NSCLC - Not a palliative regimenHarnett, P. / Taper, J. / Gurney, H. / Flynn, P. / Stuart-Harris, R. et al. | 1991
- 128
-
Pilot study of multi-cyclic combination chemotherapy (MCCCT) for extensive small cell lung cancer (SCLC)Kobayashi, Kunihiko / Kurane, Shuuji / Morikawa, Tetsuyuki / Nukariya, Naotaka / Hino, Mitsunori / Niitani, Hisanobu et al. | 1991
- 128
-
Teniposide for brain metastases of small cell lung cancer, EORTC protocol 08873| 1991